Clifford Stocks

Clifford Stocks

Chief Executive Officer at OncoResponse
Seattle, Washington, United States

Clifford Stocks is the founder of OncoResponse and currently leads the company. He previously served as Executive Officer and Director at OncoResponse Inc.

  • OncoResponse Executive Officer, Director 2017–present, Chief Executive Officer 2015–present · current
  • Theraclone Sciences Chief Executive Officer 2011–2016 · past
  • Calistoga Pharmaceuticals (acquired by Gilead 2011) Chief Business Officer 2009–2011 · past
  • ICOS Corporation (acquired by Lilly for $2.3 Billion in 2007) Vice President, Business Development 1992–2007 · past
  • Booz Allen & Hamilton Management Consultant 1989–1991 · past
  • University of Chicago Department of Molecular Genetics and Cell Biology (MGCB) Senior Research Technologist 1987–1989 · past

Education

  • The University of Chicago Booth School of Business MBA, Statistics; Operations; Leadership · 1986–1989
  • University of Utah B.S., Biology · 1976–1980

Online